Angiotensin Converting Enzyme Inhibitors - Trandolapril

Generic Name

trandolapril                                                                                                                                               
Strength

0.5 mg, 1 mg, 2 mg, 4 mg

Form

capsule

Special Authority Criteria

Approval Period

  1. Treatment failure on optimal doses of, or intolerance to, ramipril

      OR

  1. Complex patient requiring medications for co-existing chronic condition(s).

Indefinite

Practitioner Exemptions

  • Practitioners in the following specialty are not required to submit a Special Authority request form for coverage:
    • Paediatric Cardiology
    • Paediatrics

Special Notes

  • Patients with co-existing chronic conditions requiring use of multiple medications will be considered complex for the purposes of Special Authority criteria.
  • PharmaCare does not cover in trandolapril in combination with verapamil.

Special Authority Request Form(s)